FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313259500> ?p ?o ?g. }

• W4313259500 endingPage "48" @default.
• W4313259500 startingPage "48" @default.
• W4313259500 abstract "The coronavirus disease 2019 (COVID-19) that can cause extreme acute respiratory syndrome has posed a catastrophic threat to public health. The vaccines had indeed restored optimism and, after more than two years of battling the pandemic, there is renewed hope for the transition to endemicity. At the start of vaccination efforts, when supply shortages of vaccines were inevitable, every nation determined the high-risk population groups to be given priority for the COVID-19 vaccines. In this paper, the characteristics of the initial COVID-19 vaccine recipients in Malaysia are described. In line with the policies of many other countries, Malaysia firstly inoculated frontline healthcare workers, and subsequently the list of front liners grew to include defense and security personnel and those involved in the provision of essential services. People with disabilities or those with special needs and several underlying medical conditions that increased their risk of developing severe COVID-related illnesses were included in the priority categories. These included patients with severe lung disease, chronic heart disease, chronic kidney disease, chronic liver disease, neurological disease, diabetes mellitus and obesity in adults, splenic dysfunction, and severe mental illness. With little information and under circumstances of great uncertainty, the Health Ministry of a middle-income country had developed a vaccination priority-list based on the disease's epidemiology and clinical data, vaccine type, operational considerations, and risk evaluation. Early evidence was presented and suggested that the full vaccination with any of the three predominant vaccines (AZD1222, BNT162b2, and CoronaVac) in the country had been highly effective in preventing COVID-19 infections, COVID-19-related ICU admissions, and death. As many SARS-CoV-2 variants of concern (VoC), such as the Omicron BA.2/4/5, are emerging, future vaccination strategies may necessitate the need to change the immunogen of the vaccine, as well as considerations for when to give high-risk groups booster injections. These considerations are valuable for future planning by policymakers and healthcare providers to make vaccination policy and decisions, especially for the inclusion of the COVID-19 vaccines into national immunization programs." @default.
• W4313259500 created "2023-01-06" @default.
• W4313259500 creator A5011763975 @default.
• W4313259500 creator A5016923400 @default.
• W4313259500 creator A5060254611 @default.
• W4313259500 date "2022-12-26" @default.
• W4313259500 modified "2023-09-30" @default.
• W4313259500 title "COVID-19 Vaccination Prioritization Strategies in Malaysia: A Retrospective Analysis of Early Evidence" @default.
• W4313259500 cites W1495391569 @default.
• W4313259500 cites W1721371055 @default.
• W4313259500 cites W1976884472 @default.
• W4313259500 cites W1985438873 @default.
• W4313259500 cites W1993413291 @default.
• W4313259500 cites W2003982930 @default.
• W4313259500 cites W2087990468 @default.
• W4313259500 cites W2097278538 @default.
• W4313259500 cites W2099302505 @default.
• W4313259500 cites W2116251861 @default.
• W4313259500 cites W2133393736 @default.
• W4313259500 cites W2147015822 @default.
• W4313259500 cites W2163627712 @default.
• W4313259500 cites W2465777822 @default.
• W4313259500 cites W2518751885 @default.
• W4313259500 cites W2567040191 @default.
• W4313259500 cites W2764308423 @default.
• W4313259500 cites W2772192884 @default.
• W4313259500 cites W2906287592 @default.
• W4313259500 cites W2910000567 @default.
• W4313259500 cites W2981278621 @default.
• W4313259500 cites W3001456238 @default.
• W4313259500 cites W3005403371 @default.
• W4313259500 cites W3007814559 @default.
• W4313259500 cites W3008028633 @default.
• W4313259500 cites W3008090866 @default.
• W4313259500 cites W3008827533 @default.
• W4313259500 cites W3009885589 @default.
• W4313259500 cites W3011242477 @default.
• W4313259500 cites W3011605790 @default.
• W4313259500 cites W3013250171 @default.
• W4313259500 cites W3013283620 @default.
• W4313259500 cites W3016151265 @default.
• W4313259500 cites W3019267224 @default.
• W4313259500 cites W3020559522 @default.
• W4313259500 cites W3024187395 @default.
• W4313259500 cites W3025499341 @default.
• W4313259500 cites W3025528269 @default.
• W4313259500 cites W3025585828 @default.
• W4313259500 cites W3026764413 @default.
• W4313259500 cites W3037173725 @default.
• W4313259500 cites W3044229322 @default.
• W4313259500 cites W3047144258 @default.
• W4313259500 cites W3047809380 @default.
• W4313259500 cites W3048765898 @default.
• W4313259500 cites W3080808763 @default.
• W4313259500 cites W3081982443 @default.
• W4313259500 cites W3083317029 @default.
• W4313259500 cites W3084363699 @default.
• W4313259500 cites W3092219714 @default.
• W4313259500 cites W3096220157 @default.
• W4313259500 cites W3108749415 @default.
• W4313259500 cites W3111715325 @default.
• W4313259500 cites W3112209524 @default.
• W4313259500 cites W3115372941 @default.
• W4313259500 cites W3117217890 @default.
• W4313259500 cites W3117649460 @default.
• W4313259500 cites W3128190569 @default.
• W4313259500 cites W3135244418 @default.
• W4313259500 cites W3139828434 @default.
• W4313259500 cites W3154888372 @default.
• W4313259500 cites W3155433897 @default.
• W4313259500 cites W3157453497 @default.
• W4313259500 cites W3165656738 @default.
• W4313259500 cites W3216839746 @default.
• W4313259500 cites W4214913039 @default.
• W4313259500 cites W4293187294 @default.
• W4313259500 cites W4293213805 @default.
• W4313259500 cites W4293659866 @default.
• W4313259500 doi "https://doi.org/10.3390/vaccines11010048" @default.
• W4313259500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36679893" @default.
• W4313259500 hasPublicationYear "2022" @default.
• W4313259500 type Work @default.
• W4313259500 citedByCount "1" @default.
• W4313259500 countsByYear W43132595002023 @default.
• W4313259500 crossrefType "journal-article" @default.
• W4313259500 hasAuthorship W4313259500A5011763975 @default.
• W4313259500 hasAuthorship W4313259500A5016923400 @default.
• W4313259500 hasAuthorship W4313259500A5060254611 @default.
• W4313259500 hasBestOaLocation W43132595001 @default.
• W4313259500 hasConcept C107130276 @default.
• W4313259500 hasConcept C126322002 @default.
• W4313259500 hasConcept C138816342 @default.
• W4313259500 hasConcept C142724271 @default.
• W4313259500 hasConcept C159110408 @default.
• W4313259500 hasConcept C160735492 @default.
• W4313259500 hasConcept C162324750 @default.
• W4313259500 hasConcept C177713679 @default.
• W4313259500 hasConcept C203014093 @default.
• W4313259500 hasConcept C22070199 @default.

• next